|
Fatroximin Dry Cow 100/5 mg/ml
|
-
|
V/NRP/01/1372
|
Fatro S.p.A., Itālija
|
QJ51XX01
|
dry cows
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1372-01 |
100 mg/deva |
4 |
Injektors, 1 deva |
-
|
| V/NRP/01/1372-02 |
100 mg/deva |
12 |
Injektors, 1 deva |
-
|
|
|
Fatroximin 2,94 mg/g
|
-
|
V/NRP/01/1370
|
Fatro S.p.A., Itālija
|
QD06AX11
|
cattle; pigs; sheep; goats; horses; dogs; cats; rabbits
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1370-01 |
500 mg/170 g |
1 |
Alumīnija balons, 170 g |
-
|
|
|
Fatroximin 100/13.4 mg/g
|
-
|
V/NRP/01/1371
|
Fatro S.p.A., Itālija
|
QG51AA06
|
mares; cows
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
intrauterine foam
|
| International name (active substance): |
Rifaximin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
04-Jul-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 101219LI (10-Dec-2019)
|
| Labelling text: |
[PDF] 101219M (10-Dec-2019)
|
| Summary of product characteristics: |
[PDF] 101219ZA (10-Dec-2019)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1371-01 |
100 mg/deva |
6 |
Alumīnija balons, 1 deva |
-
|
|
|
Fatroximin 300/4 mg/g
|
-
|
V/NRP/01/1369
|
Fatro S.p.A., Itālija
|
QG51AA06
|
cattle; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
effervescent pessaries
|
| International name (active substance): |
Rifaximin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Fatro S.p.A., Itālija
|
| Date of authorisation/renewal: |
04-Jul-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOC] 230724LI (23-Jul-2024)
|
| Labelling text: |
[DOC] 230724M (23-Jul-2024)
|
| Summary of product characteristics: |
[DOC] 230724ZA (23-Jul-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/01/1369-01 |
300 mg/pesārijs |
12 |
Blisteris, 1 pesārijs |
-
|
| V/NRP/01/1369-02 |
300 mg/pesārijs |
36 |
Blisteris, 1 pesārijs |
-
|
|